 
                  
AstraZeneca gains $1.2 billion, poor countries to benefit in future
Nations are investing lots of money just to prevent the third wave. But, due to various issues like production issues, data disagreements, etc. vaccine is struggling to prove its credibility. Despite the issue of blood clotting, Vaccine has proved to be a huge success.
 
